![Asha Essa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Asha Essa
Profile
Asha Essa worked as a Formulation Development Chemist at INYX Pharma Ltd., a Quality Compliance Laboratory Analyst at Eli Lilly & Co. Ltd., a Laboratory Analyst at Allergan Biologics Ltd., and a Research Scientist at IOTA NanoSolutions Ltd.
She obtained an undergraduate degree from Kingston University.
Former positions of Asha Essa
Companies | Position | End |
---|---|---|
INYX Pharma Ltd.
![]() INYX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Inyx, Inc., Inyx Pharma Ltd. develops pharmaceutical products for the treatment of respiratory, allergy, dermatological, and topical conditions. The company is based in Runcorn, UK. Inyx Pharma was acquired by Doblique, Inc. on April 29, 2003 for $24.80 million. | Corporate Officer/Principal | - |
Allergan Biologics Ltd.
![]() Allergan Biologics Ltd. BiotechnologyHealth Technology Part of Pharmaron Beijing Co., Ltd., Allergan Biologics Ltd. develops biologics products. The company is based in Liverpool, UK. The British company was founded in 2002 by Bernard Chan. Allergan Biologics was acquired by Pharmaron Biologics (UK) Holdings Ltd. from AbbVie, Inc. on April 30, 2021 for $165.95 million. | Corporate Officer/Principal | - |
Eli Lilly & Co. Ltd.
![]() Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Corporate Officer/Principal | - |
IOTA NanoSolutions Ltd.
![]() IOTA NanoSolutions Ltd. Chemicals: Major DiversifiedProcess Industries IOTA NanoSolutions Ltd. is a nanomaterials engineering company that develops organic nanoparticles. It has actively developed a number of novel generic approaches to enable the formation of dry physical blends of insoluble and soluble materials. The blends are produced without a traditional particle formation step such as milling and are equally applicable with amorphous, crystalline or waxy materials. When the blends are added to a liquid the soluble material dissolves consequently releasing the insoluble material as a nanodispersion. The company was founded in 2005 and is headquartered in Liverpool, UK. | Chief Tech/Sci/R&D Officer | - |
Training of Asha Essa
Kingston University | Undergraduate Degree |
Experiences
Positions held
Linked companies
Private companies | 4 |
---|---|
IOTA NanoSolutions Ltd.
![]() IOTA NanoSolutions Ltd. Chemicals: Major DiversifiedProcess Industries IOTA NanoSolutions Ltd. is a nanomaterials engineering company that develops organic nanoparticles. It has actively developed a number of novel generic approaches to enable the formation of dry physical blends of insoluble and soluble materials. The blends are produced without a traditional particle formation step such as milling and are equally applicable with amorphous, crystalline or waxy materials. When the blends are added to a liquid the soluble material dissolves consequently releasing the insoluble material as a nanodispersion. The company was founded in 2005 and is headquartered in Liverpool, UK. | Process Industries |
Allergan Biologics Ltd.
![]() Allergan Biologics Ltd. BiotechnologyHealth Technology Part of Pharmaron Beijing Co., Ltd., Allergan Biologics Ltd. develops biologics products. The company is based in Liverpool, UK. The British company was founded in 2002 by Bernard Chan. Allergan Biologics was acquired by Pharmaron Biologics (UK) Holdings Ltd. from AbbVie, Inc. on April 30, 2021 for $165.95 million. | Health Technology |
Eli Lilly & Co. Ltd.
![]() Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Health Technology |
INYX Pharma Ltd.
![]() INYX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Inyx, Inc., Inyx Pharma Ltd. develops pharmaceutical products for the treatment of respiratory, allergy, dermatological, and topical conditions. The company is based in Runcorn, UK. Inyx Pharma was acquired by Doblique, Inc. on April 29, 2003 for $24.80 million. | Health Technology |
- Stock Market
- Insiders
- Asha Essa